Cyclosporin ointment for psoriasis and atopic dermatitis

The Lancet

Volumn 339, Issue 8801, 1992, Pages 1120-

  Mizoguchi, M ^a   Kawaguchi, K ^a   Ohsuga, Y ^a   Ikari, Y ^a   Yanagawa, A ^a   Mizushima, Y ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; AGED; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; DERMATITIS, ATOPIC; HUMAN; MIDDLE AGE; OINTMENTS; PSORIASIS;

EID: 0026525953     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90719-J     Document Type: Letter

References (5)

1. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind study
2. Efficacy of low dose cyclosporine in severe atopic skin disease
3. Cyclosporine A inhibits rat mast cell activation
4. mechanisms of action
5. The effect of cyclosporine A on epidermal cells II cyclosporine A inhibits proliferation of normal and transformed keratinocytes